Pay in 4 interest-free payments of $6.17 Learn more
Ships within 48 hours · Estimated delivery Oct 11 - Oct 16
Zhang, F., Huang, B., Zhong, B., Zhou, H., Wang, L., Zheng, Q., & Lin, Y
How Optum Rx can help you manage GLP-1/GIP trend Given the complex and evolving nature of this drug class, plan sponsors need a strategic partner with the capabilities to provide options and management strategies to help balance cost and utilization of GLP-1s
Men with obesity are also more likely to experience erectile dysfunction (ED)
However, this landscape could shift next year with the anticipated approval of: The oral version of Wegovy for obesity treatment (approved just yesterday) Eli Lillys Orforglipron
Whilst declining beta-cell function is thought to generally reduce the response to incretins, GLP-1 appeared to be the more important incretin hormone in T2D (Nauck et al, 2021)
US$ 24.51
US$ 29.88
US$ 27.47
US$ 21.52
